229 related articles for article (PubMed ID: 37760635)
21. Proteomic analyses of serous and endometrioid epithelial ovarian cancers - cases studies - molecular insights of a possible histological etiology of serous ovarian cancer.
Longuespée R; Gagnon H; Boyon C; Strupat K; Dauly C; Kerdraon O; Ighodaro A; Desmons A; Dupuis J; Wisztorski M; Vinatier D; Fournier I; Day R; Salzet M
Proteomics Clin Appl; 2013 Jun; 7(5-6):337-54. PubMed ID: 23589350
[TBL] [Abstract][Full Text] [Related]
22. The Role of KRAS in Endometrial Cancer: A Mini-Review.
Sideris M; Emin EI; Abdullah Z; Hanrahan J; Stefatou KM; Sevas V; Emin E; Hollingworth T; Odejinmi F; Papagrigoriadis S; Vimplis S; Willmott F
Anticancer Res; 2019 Feb; 39(2):533-539. PubMed ID: 30711927
[TBL] [Abstract][Full Text] [Related]
23. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
24. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
Bateman NW; Teng PN; Hope E; Hood BL; Oliver J; Ao W; Zhou M; Wang G; Tommarello D; Wilson K; Litzy T; Conrads KA; Hamilton CA; Darcy KM; Casablanca Y; Maxwell GL; Bae-Jump V; Conrads TP
Cancer Med; 2020 Feb; 9(3):1092-1103. PubMed ID: 31808620
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive proteomic signature and identification of CDKN2A as a promising prognostic biomarker and therapeutic target of colorectal cancer.
Wang QQ; Zhou YC; Zhou Ge YJ; Qin G; Yin TF; Zhao DY; Tan C; Yao SK
World J Clin Cases; 2022 Aug; 10(22):7686-7697. PubMed ID: 36158487
[TBL] [Abstract][Full Text] [Related]
26. Proteomic Analysis of Human Endometrial Tissues Reveals the Roles of PI3K/AKT/mTOR Pathway and Tumor Angiogenesis Molecules in the Pathogenesis of Endometrial Cancer.
Liu Z; Hong Z; Qu P
Biomed Res Int; 2020; 2020():5273969. PubMed ID: 32908897
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA differential expression profiles and bioinformatics analysis of hsa_circRNA_079422 in human endometrial carcinoma.
Li Y; Yang Z; Zeng M; Wang Y; Chen X; Li S; Zhao X; Sun Y
J Obstet Gynaecol; 2023 Dec; 43(2):2228894. PubMed ID: 37408092
[TBL] [Abstract][Full Text] [Related]
29. STK4 protein expression pattern follows different trends in endometrioid and serous endometrial adenocarcinoma upon tumor progression.
Govorov I; Attarha S; Kovalevska L; Andersson E; Kashuba E; Mints M
Sci Rep; 2022 Dec; 12(1):22154. PubMed ID: 36550267
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
31. A case-control study of uterine endometrial cancer of pre- and post-menopausal women.
Niwa K; Imai A; Hashimoto M; Yokoyama Y; Mori H; Matsuda Y; Tamaya T
Oncol Rep; 2000; 7(1):89-93. PubMed ID: 10601598
[TBL] [Abstract][Full Text] [Related]
32. Advances in endometrial cancer protein biomarkers for use in the clinic.
Martinez-Garcia E; Lopez-Gil C; Campoy I; Vallve J; Coll E; Cabrera S; Ramon Y Cajal S; Matias-Guiu X; Van Oostrum J; Reventos J; Gil-Moreno A; Colas E
Expert Rev Proteomics; 2018 Jan; 15(1):81-99. PubMed ID: 29183259
[TBL] [Abstract][Full Text] [Related]
33. Identification of key transcription factors in endometrial cancer by systems bioinformatics analysis.
Song Y; Chen QT; He QQ
J Cell Biochem; 2019 Sep; 120(9):15443-15454. PubMed ID: 31037767
[TBL] [Abstract][Full Text] [Related]
34. Identification of Key Prognostic-Related miRNA-mRNA Pairs in the Progression of Endometrial Carcinoma.
Dong Y; Zhang T; Li X; Yu F; Yu H; Shao S
Gynecol Obstet Invest; 2022; 87(1):12-21. PubMed ID: 35081534
[TBL] [Abstract][Full Text] [Related]
35. Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression.
Yadav VK; Lee TY; Hsu JB; Huang HD; Yang WV; Chang TH
PLoS One; 2020; 15(4):e0231594. PubMed ID: 32315343
[TBL] [Abstract][Full Text] [Related]
36. The effect of pre-analytical variables on downstream application and data analysis of human endometrial biopsies.
Maclean A; Adishesh M; Button L; Richards L; Alnafakh R; Newton E; Drury J; Hapangama DK
Hum Reprod Open; 2022; 2022(3):hoac026. PubMed ID: 35775066
[TBL] [Abstract][Full Text] [Related]
37. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
Yang Q; Yu B; Sun J
Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
[TBL] [Abstract][Full Text] [Related]
38. Proteomic analysis in endometrial cancer and endometrial hyperplasia tissues by 2D-DIGE technique.
Ceylan Y; Akpınar G; Doger E; Kasap M; Guzel N; Karaosmanoglu K; Kopuk SY; Yucesoy I
J Gynecol Obstet Hum Reprod; 2020 Feb; 49(2):101652. PubMed ID: 31783195
[TBL] [Abstract][Full Text] [Related]
39. RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma.
Liu S; Lin M; Ji H; Ding J; Zhu J; Ma R; Meng F
Diagn Pathol; 2019 Jan; 14(1):7. PubMed ID: 30684972
[TBL] [Abstract][Full Text] [Related]
40. Implications of telomeres and telomerase in endometrial pathology.
Hapangama DK; Kamal A; Saretzki G
Hum Reprod Update; 2017 Mar; 23(2):166-187. PubMed ID: 27979878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
